DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /GPCR & G Protein TargetsGPCR & G Protein Targets
  5. /RasRas
  6. /GarsorasibGarsorasib
Chemical structure of CAS 2559761-14-5

Garsorasib

In Stock•Starting at $380 for 25 mg•Purity ≥ 95%
CAS No.2559761-14-5
MDL No.N/A
MFC32H32F2N8O2
MW598.60
InChI KeyDKFRWZJCNPETGI-SJORKVTESA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
25 mg95%$380In Stock
50 mg95%$662In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2559761-14-5
Product NameGarsorasib
Heavy Atom Count44Rotatable Bond Count6
Atom Stereo Count2Bond Stereo Count0
HBA9HBD1
TPSA123.130 ŲCharge0
Exact Mass598.26163Complexity1851.42
pKa7.130XLogP4.465

Related Articles

Studies related to this compound and its mechanism of action

New drugs approved by the NMPA in 2024: Synthesis and clinical applications.

European journal of medicinal chemistry • Vol. 291 • 2025
PMID: 40262297DOI: 10.1016/j.ejmech.2025.117643

D-1553: A novel KRAS inhibitor with potent and selective cellular and in vivo antitumor activity.

Cancer science • Vol. 114, Issue 7 • 2023
PMID: 37158138PMC: PMC10323112DOI: 10.1111/cas.15829

Documentation

Similar Products

  • Sotorasib

    CAS No.2296729-00-3

  • Glecirasib

    CAS No.2657613-87-9

  • Fulzerasib

    CAS No.2641747-54-6

  • Cefilavancin

    CAS No.722454-12-8

  • Orforglipron

    CAS No.2212020-52-3

  • Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-

    CAS No.162652-95-1

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact